Definitive Contract 00261200106D261017002
Ended Awarded Last action
- Contract number
- 00261200106D261017002
- Awardee
-
Charles River Laboratories, Inc. UEI NAPSK1UAMAE5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,755,000
Award facts
- Contract value 14% obligated
- $12,845,232.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Maryland, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $400,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $200,000 | |
| Supplemental Agreement for work within scope | $370,000 | |
| Supplemental Agreement for work within scope | $75,000 | |
| Original award | $710,000 |
About this award
This is a definitive federal contract awarded by a U.S. government agency to Charles River Laboratories, Inc., a for-profit organization that manufactures goods. The contract has a potential value of $12,845,232.00 and was awarded on June 15, 2001 with a completion date of May 31, 2006. It is a cost-plus-fixed-fee contract with no set-aside designation.
Charles River Laboratories provides essential products and services to support drug discovery, early-stage development, and manufacturing of novel drugs and therapeutics. Under this and other prime and subcontracts, the company has delivered various research models, services, and specialty products to federal health agencies like the National Institutes of Health, Department of Veterans Affairs, Food and Drug Administration, and Department of Defense. This includes laboratory animals, diagnostics, cell line production, vaccine development support, disease models, and other research-related services spanning the drug development lifecycle.
Charles River Laboratories also holds several indefinite delivery contracts (IDCs) and blanket purchase agreements (BPAs) with federal agencies to supply research models and services over extended periods, including a $94 million IDC with the National Institute on Aging for aged rodent colonies and a BPA with the Food and Drug Administration for embryo/sperm cryopreservation.
Quick answers
Who was awarded contract 00261200106D261017002?
00261200106D261017002 was awarded to Charles River Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on June 15, 2001.
How much is contract 00261200106D261017002 worth?
The government has obligated $1,755,000 on 00261200106D261017002. Its current value, with exercised options, is $12,845,232.
Was contract 00261200106D261017002 competed?
The extent of competition for 00261200106D261017002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award